Rathore Vipin K, Singh Sandeep, Yadav Nidheesh
Department of Yoga Science, University of Patanjali, Haridwar, Uttarakhand, 249405, India.
Department of Yoga Science, University of Patanjali, Haridwar, Uttarakhand, 249405, India.
J Ayurveda Integr Med. 2025 Sep-Oct;16(5):101189. doi: 10.1016/j.jaim.2025.101189. Epub 2025 Sep 5.
This study aims to investigate the impact of yoga practice on pulmonary and respiratory functions in clinical populations. A thorough search was carried out in the Cochrane Library, PubMed, Science Direct databases, and Google Scholar, using the keywords "Yog∗" and "pulmonary functions", covering the period from January 2010 to December 2022. Studies that aligned with PRISMA recommendations were included. The Cochrane risk-assessment tool was employed to assess bias risk. We calculated weighted mean differences (WMDs) with 95 % confidence intervals (CIs) and used the I test to assess heterogeneity. Initially, 529 studies were found through the search, with 10 randomized controlled trials (RCTs) involving 1007 patients meeting the inclusion criteria for quality assessment and meta-analysis. The results indicated that yoga intervention (YI) significantly improved FVC% (WMD: 3.03 L, 95 % CI: 1.71, 4.35, P < 0.00001), FEV1 (WMD: 0.47 L, 95 % CI: 0.43, 0.51, P < 0.00001), and FEV1% (WMD: 5.74 L, 95 % CI: 4.47, 7.01, P < 0.00001) when compared to control groups. However, no significant effect was observed on FVC (WMD: 0.23 L, CI: 0.16, 0.62. P = 0.25), PEFR (WMD: 0.49, CI: 0.70, 1.67, P = 0.42), MVV (WMD: 9.01, CI: 3.92, 21.94, P = 0.17), and FEV1/FVC (WMD: 3.17, CI: 1.15, 7.48, P = 0.15) as a result of YI. Based on the limited evidence and meta-analysis conducted, YI demonstrated a positive effect on pulmonary function in clinical populations and could be considered as an adjunct therapy for individuals with various respiratory diseases. Further rigorous research with larger sample sizes is necessary to confirm the long-term benefits of yoga.
本研究旨在调查瑜伽练习对临床人群肺功能和呼吸功能的影响。在考克兰图书馆、PubMed、科学Direct数据库和谷歌学术中进行了全面检索，使用关键词“Yog∗”和“肺功能”，涵盖2010年1月至2022年12月期间。纳入符合PRISMA建议的研究。采用考克兰风险评估工具评估偏倚风险。我们计算了加权平均差（WMD）及其95%置信区间（CI），并使用I检验评估异质性。最初，通过检索找到529项研究，其中10项随机对照试验（RCT）涉及1007名符合质量评估和荟萃分析纳入标准的患者。结果表明，与对照组相比，瑜伽干预（YI）显著改善了用力肺活量百分比（FVC%）（WMD：3.03L，95%CI：1.71，4.35，P<0.00001）、第一秒用力呼气容积（FEV1）（WMD：0.47L，95%CI：0.43，0.51，P<0.00001）和FEV1%（WMD：5.74L，95%CI：4.47，7.01，P<0.00001）。然而，瑜伽干预对用力肺活量（FVC）（WMD：0.23L，CI：0.16，0.62，P=0.25）、呼气峰值流速（PEFR）（WMD：0.49，CI：0.70，1.67，P=0.42）、最大通气量（MVV）（WMD：9.01，CI：3.92，21.94，P=0.17）和FEV1/FVC（WMD：3.17，CI：1.15，7.48，P=0.15）没有显著影响。基于有限的证据和进行的荟萃分析，瑜伽干预对临床人群的肺功能显示出积极作用，可被视为各种呼吸系统疾病患者的辅助治疗方法。需要进一步进行更大样本量的严谨研究来证实瑜伽的长期益处。
